Effects of dopaminergic treatment on putaminal dopamine turnover measured with 18F-Dopa-PET in Parkinson's disease

被引：0
|
作者：
Wolz, M. [1 ]
Beuthien-Baumann, B. [2 ]
Loehle, M. [1 ]
Herting, B. [1 ]
Oehme, L. [2 ]
van den Hoff, J. [3 ]
Perick, M. [2 ]
Kotzerke, J. [2 ]
Reichmann, H. [1 ]
Storch, A. [1 ]
机构：
[1] Tech Univ Dresden, Dept Neurol, Dresden, Germany
[2] Tech Univ Dresden, Dept Nucl Med, Dresden, Germany
[3] Forschungszentrum Dresden Rossendorf, Positron Emiss Tomog Div, Dresden, Germany
来源：
PARKINSONISM & RELATED DISORDERS | 2009年 / 15卷
关键词：
D O I：
10.1016/S1353-8020(09)70222-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.100
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [21] Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-Dopa PET study
    Pavese, N.
    Rivero-Bosch, M.
    Lewis, S. J.
    Brooks, D. J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S154 - S154
  • [22] Extrastriatal monoamine neuron function in Parkinson's disease:: An 18F-dopa PET study
    Moore, Robert Y.
    Whone, Alan L.
    BrookSa, David J.
    NEUROBIOLOGY OF DISEASE, 2008, 29 (03) : 381 - 390
  • [23] A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease
    Hu, MTM
    White, SJ
    Herlihy, AH
    Chaudhuri, KR
    Hajnal, JV
    Brooks, DJ
    NEUROLOGY, 2001, 56 (09) : 1195 - 1200
  • [24] An [F-18]dopa-PET and clinical study of the rate of progression in Parkinson's disease
    Morrish, PK
    Sawle, GV
    Brooks, DJ
    BRAIN, 1996, 119 : 585 - 591
  • [25] Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease
    Ito, K
    Morrish, PK
    Rakshi, JS
    Uema, T
    Ashburner, J
    Bailey, DL
    Friston, KJ
    Brooks, DJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (06): : 754 - 758
  • [26] Difference in multiple system atrophy and Parkinson's disease by F-18-dopa and F-18-FDG/PET.
    Otsuka, M
    Ichiya, Y
    Kuwabara, Y
    Sasaki, M
    Yoshida, T
    Fukumura, T
    Kato, M
    Masuda, K
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1212 - 1212
  • [27] Comparison of PET tracers for dopamine terminals in Parkinson's disease:: Evidence for aging effects in 11C-MP and regulatory changes in 18F-DOPA
    Troiano, AR
    Schulzer, M
    Sossi, V
    Ruth, TJ
    Calne, DB
    Stoessl, AJ
    MOVEMENT DISORDERS, 2004, 19 : S381 - S382
  • [28] THE UTILITY OF 18F-DOPA IN THE INVESTIGATION OF PARKINSON'S DISEASE
    Frecker, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 32 - 32
  • [29] Tremor at diagnosis is predictive of slower disease progression in Parkinson's disease:: An 18F DOPA PET study
    Whone, AL
    Brefel-Courbon, C
    Moore, RY
    Rascol, O
    Brooks, DJ
    MOVEMENT DISORDERS, 2002, 17 : S140 - S141
  • [30] Dopaminergic function in familial Parkinson's disease: A clinical and F-18-dopa positron emission tomography study
    Piccini, P
    Morrish, PK
    Turjanski, N
    Sawle, GV
    Burn, DJ
    Weeks, RA
    Mark, MH
    Maraganore, DM
    Lees, AJ
    Brooks, DJ
    ANNALS OF NEUROLOGY, 1997, 41 (02) : 222 - 229
12345